Literature DB >> 24355813

Inflammatory pathways of seizure disorders.

Nicola Marchi1, Tiziana Granata2, Damir Janigro3.   

Abstract

Epilepsy refers to a cluster of neurological diseases characterized by seizures. Although many forms of epilepsy have a well-defined immune etiology, in other forms of epilepsy an altered immune response is only suspected. In general, the hypothesis that inflammation contributes to seizures is supported by experimental results. Additionally, antiepileptic maneuvers may act as immunomodulators and anti-inflammatory therapies can treat seizures. Triggers of seizure include a bidirectional communication between the nervous system and organs of immunity. Thus, a crucial cellular interface protecting from immunological seizures is the blood-brain barrier (BBB). Here, we summarize recent advances in the understanding and treatment of epileptic seizures that derive from a non-neurocentric viewpoint and suggest key avenues for future research.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  antiepileptic drugs; blood–brain barrier; corticosteroids; immunomodulatory axis; infection; inflammation; vagus nerve stimulation

Mesh:

Year:  2013        PMID: 24355813      PMCID: PMC3977596          DOI: 10.1016/j.tins.2013.11.002

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  110 in total

1.  Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures.

Authors:  Mattia Maroso; Silvia Balosso; Teresa Ravizza; Jaron Liu; Eleonora Aronica; Anand M Iyer; Carlo Rossetti; Monica Molteni; Maura Casalgrandi; Angelo A Manfredi; Marco E Bianchi; Annamaria Vezzani
Journal:  Nat Med       Date:  2010-03-28       Impact factor: 53.440

2.  Microglial activation and TNFalpha production mediate altered CNS excitability following peripheral inflammation.

Authors:  Kiarash Riazi; Michael A Galic; J Brent Kuzmiski; Winnie Ho; Keith A Sharkey; Quentin J Pittman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-27       Impact factor: 11.205

Review 3.  Management of the patient with medically refractory epilepsy.

Authors:  Tiziana Granata; Nicola Marchi; Erin Carlton; Chaitali Ghosh; Jorge Gonzalez-Martinez; Andreas V Alexopoulos; Damir Janigro
Journal:  Expert Rev Neurother       Date:  2009-12       Impact factor: 4.618

4.  Increased activation of Iba1+ microglia in pediatric epilepsy patients with Rasmussen's encephalitis compared with cortical dysplasia and tuberous sclerosis complex.

Authors:  Martin Wirenfeldt; Ryan Clare; Spencer Tung; Alexander Bottini; Gary W Mathern; Harry V Vinters
Journal:  Neurobiol Dis       Date:  2009-03-10       Impact factor: 5.996

5.  Suppressive effect of diazepam on IFN-gamma production by human T cells.

Authors:  Min Wei; Li Li; Rui Meng; Yanying Fan; Yun Liu; Liang Tao; Xianguo Liu; Changyou Wu
Journal:  Int Immunopharmacol       Date:  2009-11-13       Impact factor: 4.932

Review 6.  Contributions of peripheral inflammation to seizure susceptibility: cytokines and brain excitability.

Authors:  Kiarash Riazi; Michael A Galic; Quentin J Pittman
Journal:  Epilepsy Res       Date:  2009-10-04       Impact factor: 3.045

7.  A role for leukocyte-endothelial adhesion mechanisms in epilepsy.

Authors:  Paolo F Fabene; Graciela Navarro Mora; Marianna Martinello; Barbara Rossi; Flavia Merigo; Linda Ottoboni; Simona Bach; Stefano Angiari; Donatella Benati; Asmaa Chakir; Lara Zanetti; Federica Schio; Antonio Osculati; Pasquina Marzola; Elena Nicolato; Jonathon W Homeister; Lijun Xia; John B Lowe; Rodger P McEver; Francesco Osculati; Andrea Sbarbati; Eugene C Butcher; Gabriela Constantin
Journal:  Nat Med       Date:  2008-11-23       Impact factor: 53.440

Review 8.  Antibodies and neuronal autoimmune disorders of the CNS.

Authors:  Francesc Graus; Albert Saiz; Josep Dalmau
Journal:  J Neurol       Date:  2009-12-25       Impact factor: 4.849

9.  Chemokine CCL2 and its receptor CCR2 are increased in the hippocampus following pilocarpine-induced status epilepticus.

Authors:  Maira L Foresti; Gabriel M Arisi; Khurshed Katki; Andres Montañez; Russell M Sanchez; Lee A Shapiro
Journal:  J Neuroinflammation       Date:  2009-12-24       Impact factor: 8.322

10.  The role of potassium in inflammasome activation by bacteria.

Authors:  Cecilia S Lindestam Arlehamn; Virginie Pétrilli; Olaf Gross; Jürg Tschopp; Tom J Evans
Journal:  J Biol Chem       Date:  2010-01-22       Impact factor: 5.157

View more
  63 in total

1.  Imaging robust microglial activation after lipopolysaccharide administration in humans with PET.

Authors:  Christine M Sandiego; Jean-Dominique Gallezot; Brian Pittman; Nabeel Nabulsi; Keunpoong Lim; Shu-Fei Lin; David Matuskey; Jae-Yun Lee; Kevin C O'Connor; Yiyun Huang; Richard E Carson; Jonas Hannestad; Kelly P Cosgrove
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-18       Impact factor: 11.205

Review 2.  Infections, inflammation and epilepsy.

Authors:  Annamaria Vezzani; Robert S Fujinami; H Steve White; Pierre-Marie Preux; Ingmar Blümcke; Josemir W Sander; Wolfgang Löscher
Journal:  Acta Neuropathol       Date:  2015-09-30       Impact factor: 17.088

Review 3.  Defining the therapeutic time window for suppressing the inflammatory prostaglandin E2 signaling after status epilepticus.

Authors:  Yifeng Du; Timothy Kemper; Jiange Qiu; Jianxiong Jiang
Journal:  Expert Rev Neurother       Date:  2016-01-13       Impact factor: 4.618

4.  Albumin induces excitatory synaptogenesis through astrocytic TGF-β/ALK5 signaling in a model of acquired epilepsy following blood-brain barrier dysfunction.

Authors:  Itai Weissberg; Lydia Wood; Lyn Kamintsky; Oscar Vazquez; Dan Z Milikovsky; Allyson Alexander; Hannah Oppenheim; Carolyn Ardizzone; Albert Becker; Federica Frigerio; Annamaria Vezzani; Marion S Buckwalter; John R Huguenard; Alon Friedman; Daniela Kaufer
Journal:  Neurobiol Dis       Date:  2015-03-30       Impact factor: 5.996

5.  Chemokine CCL2-CCR2 Signaling Induces Neuronal Cell Death via STAT3 Activation and IL-1β Production after Status Epilepticus.

Authors:  Dai-Shi Tian; Jiyun Peng; Madhuvika Murugan; Li-Jie Feng; Jun-Li Liu; Ukpong B Eyo; Li-Jun Zhou; Rochelle Mogilevsky; Wei Wang; Long-Jun Wu
Journal:  J Neurosci       Date:  2017-07-17       Impact factor: 6.167

6.  Expression of MicroRNAs miR-145, miR-181c, miR-199a and miR-1183 in the Blood and Hippocampus of Patients with Mesial Temporal Lobe Epilepsy.

Authors:  Luana Grupioni Lourenço Antônio; Priscila Freitas-Lima; Gabriela Pereira-da-Silva; João Alberto Assirati; Caio Marconato Matias; Mucio Luiz Assis Cirino; Luis Fernando Tirapelli; Tonicarlo Rodrigues Velasco; Americo Ceiki Sakamoto; Carlos Gilberto Carlotti; Daniela Pretti da Cunha Tirapelli
Journal:  J Mol Neurosci       Date:  2019-07-31       Impact factor: 3.444

Review 7.  Cerebral Toxocariasis: Silent Progression to Neurodegenerative Disorders?

Authors:  Chia-Kwung Fan; Celia V Holland; Karen Loxton; Ursula Barghouth
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

8.  Lack of CAR impacts neuronal function and cerebrovascular integrity in vivo.

Authors:  Baddreddine Boussadia; Giuseppe Gangarossa; Laila Mselli-Lakhal; Marie-Claude Rousset; Frederic de Bock; Frederic Lassere; Chaitali Ghosh; Jean-Marc Pascussi; Damir Janigro; Nicola Marchi
Journal:  Exp Neurol       Date:  2016-05-27       Impact factor: 5.330

Review 9.  Autoimmune seizures and epilepsy.

Authors:  Christian Geis; Jesus Planagumà; Mar Carreño; Francesc Graus; Josep Dalmau
Journal:  J Clin Invest       Date:  2019-02-04       Impact factor: 14.808

Review 10.  Breakdown of blood brain barrier as a mechanism of post-traumatic epilepsy.

Authors:  Aaron Dadas; Damir Janigro
Journal:  Neurobiol Dis       Date:  2018-07-18       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.